{"id":43077,"date":"2023-07-18T11:19:05","date_gmt":"2023-07-18T03:19:05","guid":{"rendered":"https:\/\/biopioneer.com.tw\/?p=43077"},"modified":"2023-07-18T11:20:09","modified_gmt":"2023-07-18T03:20:09","slug":"ki67-%e8%85%ab%e7%98%a4%e6%83%a1%e6%80%a7%e7%a8%8b%e5%ba%a6%e7%9a%84%e6%a8%99%e8%a8%98%e7%89%a9-%e7%99%8c%e7%97%87%e7%9a%84%e9%a0%90%e5%be%8c%e5%92%8c%e6%b2%bb%e7%99%82","status":"publish","type":"post","link":"http:\/\/biopioneer.com.tw\/?p=43077","title":{"rendered":"Ki67 (\u816b\u7624\u60e1\u6027\u7a0b\u5ea6\u7684\u6a19\u8a18\u7269) | \u764c\u75c7\u7684\u9810\u5f8c\u548c\u6cbb\u7642"},"content":{"rendered":"<p><span style=\"color: #993366;\"><strong><span style=\"font-size: 14pt;\">Ki67 (\u816b\u7624\u60e1\u6027\u7a0b\u5ea6\u7684\u6a19\u8a18\u7269) |<span style=\"color: #ff9900;\"> \u764c\u75c7\u7684\u9810\u5f8c\u548c\u6cbb\u7642<\/span><\/span><\/strong><\/span><\/p>\n<p><span style=\"color: #33cccc;\">Ki67 \u5b58\u5728\u65bc\u7d30\u80de\u6838\u4e2d\uff0c\u662f\u7d30\u80de\u589e\u6b96\u7684\u6a19\u8a8c\u7269\uff0c\u5728\u591a\u7a2e\u764c\u75c7\u4e2d\u5177\u6709\u8a3a\u65b7\u548c\u9810\u5f8c\u50f9\u503c\u3002Ki67 \u6838\u6297\u539f\u5728\u7d30\u80de\u9031\u671f\u7684 G1 \u671f\u3001 S \u671f\u3001 G2 \u671f\u548c M \u671f\u4e2d\u8868\u9054\uff0c\u4f46\u5728 G0 \u671f\u4e2d\u4e0d\u8868\u9054\u3002\u5b83\u5728 G1 \u671f\u5ea7\u843d\u5728\u6838\u9031\u5340\u57df\uff0c\u4e26\u5728\u96a8\u5f8c\u7684\u968e\u6bb5\u5206\u4f48\u65bc\u6574\u500b\u6838\u5167\u90e8\u3002\u5728\u6709\u7d72\u5206\u88c2\u671f\u9593\uff0c\u5b83\u5b58\u5728\u65bc\u6240\u6709\u67d3\u8272\u9ad4\u4e0a\u3002<\/span><\/p>\n<p><strong><span style=\"font-size: 12pt; color: #800000;\">\u764c\u75c7\u7684\u9810\u5f8c\u548c\u6cbb\u7642<\/span><\/strong><\/p>\n<p>Ki67 \u88ab\u7528\u4f5c\u5224\u5225\u816b\u7624\u60e1\u6027\u7a0b\u5ea6\u7684\u6a19\u8a18\u7269\uff0c\u5728\u764c\u75c7\u8a3a\u65b7\u548c\u6cbb\u7642\u904e\u7a0b\u4e2d\u5177\u6709\u8a55\u4f30\u9810\u5f8c\u548c\u9810\u6e2c\u50f9\u503c [1\u20135]\u3002 \u4f8b\u5982\uff0c\u5c0d\u65bc\u6dcb\u5df4\u7d50\u9670\u6027\u4e73\u817a\u764c\uff0c Ki67 \u53ef\u4ee5\u70ba\u81e8\u5e8a\u91ab\u751f\u63d0\u4f9b\u9664\u4e86\u8af8\u5982\u96cc\u6fc0\u7d20\u53d7\u9ad4\u3001\u5b55\u6fc0\u7d20\u53d7\u9ad4\u548c\u4eba\u8868\u76ae\u751f\u9577\u56e0\u5b50\u539f\u4f4d\u96dc\u4ea4 (HER2-ISH) \u7b49\u81e8\u5e8a\u75c5\u7406\u5b78\u8b8a\u91cf\u4e4b\u5916\u7684\u5176\u4ed6\u8f14\u52a9\u5224\u65b7\u4f9d\u64da [2]\u3002 \u5728\u4e0a\u76ae\u6a23\u60e1\u6027\u80f8\u819c\u9593\u76ae\u7624 (MPM) \u4e2d\uff0c Ki67 \u4e5f\u662f\u4e00\u7a2e\u975e\u4f9d\u8cf4\u6027\u9810\u5f8c\u56e0\u5b50 [6]\uff0c\u4e73\u817a\u764c\u5c08\u5bb6\u53ef\u4ee5\u85c9\u7531 Ki67 \u6307\u6578\u4f5c\u51fa\u95dc\u65bc\u4f7f\u7528\u8f14\u52a9\u5316\u7642\u7684\u81e8\u5e8a\u6c7a\u7b56 [7]\u3002<\/p>\n<p>\u7136\u800c\uff0c\u5c0d\u65bc Ki67 \u9810\u6e2c\u5316\u7642\u7642\u6548\u7684\u6307\u6a19\u6027\u4ecd\u5177\u6709\u722d\u8b70\u6027\u3002 \u6700\u65b0\u6578\u64da\u986f\u793a\uff0c\u5c0d\u65bc\u50c5\u6709 1-3 \u500b\u967d\u6027\u814b\u7aa9\u6dcb\u5df4\u7d50\u7684\u65e9\u671f\u4e73\u817a\u764c\u60a3\u8005\u4f86\u8aaa\uff0c\u5229\u7528 Ki67 \u7684\u8868\u9054\u6307\u6578\u5224\u65b7\u60a3\u8005\u662f\u5426\u9032\u884c\u8f14\u52a9\u5316\u7642\u4e26\u4e0d\u5408\u9069 [8]\u3002 \u7531\u65bc\u7f3a\u4e4f\u8db3\u5920\u7684\u6578\u64da\u652f\u6301\uff0c\u7f8e\u570b\u81e8\u5e8a\u816b\u7624\u5b78\u6703 (ASCO) \u816b\u7624\u6a19\u8a8c\u7269\u6307\u5c0e\u59d4\u54e1\u6703\u4e0d\u5efa\u8b70\u5c07 Ki67 \u4f5c\u70ba\u65b0\u8fd1\u8a3a\u65b7\u70ba\u4e73\u817a\u764c\u7684\u60a3\u8005\u7684\u5e38\u898f\u9810\u5f8c\u6a19\u8a8c\u7269 [9]\u3002<\/p>\n<p><span style=\"color: #800000;\"><strong><span style=\"font-size: 12pt;\">\u6210\u5c31\u66f4\u597d\u7684\u6a19\u8a8c\u7269<\/span><\/strong><\/span><\/p>\n<p>\u6709\u95dc\u8a55\u4f30\u548c\u6539\u9032 Ki67 \u81e8\u5e8a\u6548\u7528\u7684\u7814\u7a76\u6b63\u5728\u9032\u884c\u4e2d\u3002 \u4f7f\u7528\u57fa\u65bc\u4e2d\u592e\u67d3\u8272\u7d44\u7e54\u5fae\u9663\u5217\u5207\u7247\u7684\u8a55\u5206\u65b9\u6cd5\u6709\u52a9\u65bc\u514b\u670d Ki67 \u8a55\u5206\u4e2d\u7684\u91cd\u8907\u6027\u554f\u984c\uff0c\u4f46\u9019\u4e00\u7b56\u7565\u4ecd\u5f85\u958b\u767c\u5b8c\u5584 [10]\u3002\u76ee\u524d\uff0c\u4e00\u9805\u81e8\u5e8a\u5be6\u9a57 (POETIC) \u6b63\u5728\u9032\u884c\u4e2d\uff0c\u8a72\u81e8\u5e8a\u5be6\u9a57\u76ee\u7684\u662f\u78ba\u5b9a\u5728\u63a5\u53d7\u5167\u5206\u6ccc\u6cbb\u7642\u5f8c\uff0c\u5207\u9664\u7684\u816b\u7624\u4e2d\uff0c\u5229\u7528\u514d\u75ab\u7d44\u7e54\u5316\u5b78\u67d3\u8272\u65b9\u6cd5\u6e2c\u5f97\u7684 Ki67\u3001\u8207\u6cbb\u7642\u524d\u7684 Ki67 \u6578\u503c\u76f8\u6bd4\uff0c\u662f\u5426\u80fd\u5920\u66f4\u597d\u5730\u9810\u6e2c\u764c\u75c7\u5fa9\u767c\u6642\u9593 [11]\u3002\u6700\u5f8c\uff0c\u8207\u55ae\u7368\u6aa2\u6e2c Ki67 \u76f8\u6bd4\uff0c\u4e00\u7a2e\u65b0\u578b\u7684\u57fa\u65bc\u91cf\u5b50\u9ede\u7684\u539f\u4f4d\u87a2\u5149\u6210\u50cf\u6280\u8853 \u2014\u2014 \u540c\u6642\u6aa2\u6e2c Ki67 \u548c\u7d30\u80de\u89d2\u86cb\u767d\uff08Cytokeratin, \u4e00\u7a2e\u4e0a\u76ae\u7d30\u80de\u7279\u7570\u6027\u6a19\u8a8c\u7269\uff09\uff0c\u662f\u66f4\u597d\u7684\u4e73\u817a\u764c\u9810\u5f8c\u6307\u6a19\uff0c\u53ef\u4ee5\u66f4\u7c21\u55ae\u6e96\u78ba\u5730\u5c0d\u7d50\u679c\u9032\u884c\u89e3\u8b80 [12]\u3002\u63d0\u9ad8\u6297\u9ad4\u7684\u53ef\u9760\u6027\u986f\u7136\u6703\u5c0d Ki67 \u4f5c\u70ba\u764c\u75c7\u8a3a\u65b7\u548c\u9810\u5f8c\u6a19\u8a8c\u7269\u7684\u9810\u6e2c\u80fd\u529b\u7522\u751f\u5de8\u5927\u5f71\u97ff\u3002<\/p>\n<p><a href=\"https:\/\/www.abcam.com\/primary-antibodies\/knockout-validation\" target=\"_blank\" rel=\"noopener\">\u5254\u9664\u9a57\u8b49 (Knockout validation)<\/a>\u00a0\u53ef\u78ba\u4fdd\u6297\u9ad4\u5c08\u4e00\u6027\u5728\u771f\u6b63\u610f\u7fa9\u7684\u9670\u6027\u5c0d\u7167\u6a23\u672c\u4e2d\u5f97\u5230\u9a57\u8b49\uff0c\u7d93\u5254\u9664\u9a57\u8b49\u7684\u6297\u9ad4\u6709\u52a9\u65bc\u5728\u9032\u884c\u6a19\u6e96\u5316\u6e2c\u8a66\u6642\uff0c\u6d88\u9664\u5be6\u9a57\u5ba4\u9593\u548c\u5be6\u9a57\u5ba4\u5167\u4e0d\u5fc5\u8981\u7684\u5dee\u7570\u3002 Abcam \u64c1\u6709\u4e09\u7a2e\u7d93\u5254\u9664\u9a57\u8b49 (\u65bc Datasheet \u4e0a\u6a19\u793a\u70ba KO Validated) \u7684\u6297 Ki67 \u6297\u9ad4\uff0c\u9019\u4e9b\u6297\u9ad4\u88ab 1800 \u591a\u7bc7\u79d1\u5b78\u6587\u737b\u5f15\u7528\u3002<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abcam.com\/ps\/products\/15\/ab15580\/Images\/ab15580-248320-anti-ki67-antibody-immunohistochemistry.jpg\" \/><\/p>\n<div class=\"legend__title\"><strong><span style=\"color: #800000; font-size: 12pt;\">\u514d\u75ab\u7d44\u7e54\u5316\u5b78\uff08\u798f\u723e\u99ac\u6797\/PFA \u56fa\u5b9a\u77f3\u881f\u5305\u57cb\u5207\u7247\uff09- \u6297 Ki67 \u6297\u9ad4 (ab15580)<\/span><\/strong><\/div>\n<div class=\"legend__description\">\n<p>\u5c0f\u9f20\u813e\u81df\u798f\u723e\u99ac\u6797\u56fa\u5b9a\u77f3\u881f\u5305\u57cb\u7d44\u7e54\u5207\u7247\u4e2d ab15580 \u67d3\u8272\u7684 IHC \u5716\u50cf\uff0c\u4f7f\u7528\u6a19\u6e96\u65b9\u6848 B \u5728 Leica Bond\u00a0<sup>TM<\/sup>\u7cfb\u7d71\u4e0a\u9032\u884c\u3002\u4f7f\u7528\u6ab8\u6aac\u9178\u9209\u7de9\u885d\u6db2 (pH6) \u4f7f\u7528\u71b1\u4ecb\u5c0e\u6297\u539f\u4fee\u5fa9\u5c0d\u5207\u7247\u9032\u884c 20 \u5206\u9418\u9810\u8655\u7406\u3002\u7136\u5f8c\u5c07\u5207\u7247\u8207 ab15580 (5\u00b5g\/ml) \u5728\u5ba4\u6eab\u4e0b\u5b75\u80b2 15 \u5206\u9418\u3002\u4f7f\u7528\u5c71\u7f8a\u6297\u5154\u751f\u7269\u7d20\u5316\u4e8c\u6297\u6aa2\u6e2c\u4e00\u6297\uff0c\u4e26\u4f7f\u7528 HRP \u5076\u806f ABC \u7cfb\u7d71\u9032\u884c\u53ef\u8996\u5316\u3002DAB \u7528\u4f5c\u8272\u539f\u9ad4\u3002\u7136\u5f8c\u5c07\u5207\u7247\u7528\u8607\u6728\u7cbe\u8907\u67d3\u4e26\u7528 DPX \u5c01\u7247\u3002<\/p>\n<\/div>\n<p>Abcam KO-validated anti-Ki67 antibodies<br \/>\nRabbit polyclonal\u00a0<a href=\"https:\/\/www.abcam.com\/ki67-antibody-ab15580.html\" target=\"_blank\" rel=\"noopener\">anti-Ki67 (ab15580)<\/a><\/p>\n<ul>\n<li>\u7d93\u9a57\u8b49\u53ef\u7528\u65bc IHC &#8211; Wholemount, IHC-P, IHC-FrFl, Flow Cyt, ICC\/IF, ICC \u3002<\/li>\n<li>1145 \u591a\u7bc7\u79d1\u5b78\u6587\u737b\u5f15\u7528\uff0c\u8d85\u904e 175 \u5247\u4f7f\u7528\u8005\u5fc3\u5f97\u8a55\u8ad6\uff0c\u5ba2\u6236\u8a55\u50f9\u4e94\u9846\u661f\u3002<\/li>\n<\/ul>\n<p>Rabbit monoclonal [SP6]\u00a0<a href=\"https:\/\/www.abcam.com\/ki67-antibody-sp6-ab16667.html\" target=\"_blank\" rel=\"noopener\">anti-Ki67 (ab16667)<\/a><\/p>\n<ul>\n<li><a href=\"https:\/\/www.abcam.com\/primary-antibodies\/why-a-rabmab-primary-isnt-the-same-as-any-other-antibody-1\" target=\"_blank\" rel=\"noopener\">RabMAb\u00ae<\/a>\u00a0\u5c08\u5229\u6280\u8853\u63d0\u4f9b\u5353\u8d8a\u7684\u7d50\u5408\u89aa\u548c\u529b\u548c\u751f\u7269\u6d3b\u6027\u3002<\/li>\n<li>\u7d93\u9a57\u8b49\u53ef\u7528\u65bc IHC-FoFr, ICC\/IF, Flow Cyt, IHC-Fr, WB, IHC-P \u3002<\/li>\n<li>640 \u591a\u7bc7\u79d1\u5b78\u6587\u737b\u5f15\u7528\uff0c\u8d85\u904e 85 \u5247\u4f7f\u7528\u8005\u5fc3\u5f97\u8a55\u8ad6\uff0c\u5ba2\u6236\u8a55\u50f9\u4e94\u9846\u661f\u3002<\/li>\n<\/ul>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"https:\/\/www.abcam.com\/ps\/products\/16\/ab16667\/Images\/ab16667-511697-anti-ki67-antibody-sp6-immunohistochemistry-colon-carcinoma-human.jpg\" width=\"609\" height=\"859\" \/><\/p>\n<div class=\"legend__title\"><span style=\"color: #800000;\"><strong><span style=\"font-size: 12pt;\">\u514d\u75ab\u7d44\u7e54\u5316\u5b78\uff08\u798f\u723e\u99ac\u6797\/PFA \u56fa\u5b9a\u77f3\u881f\u5305\u57cb\u5207\u7247\uff09- \u6297 Ki67 \u6297\u9ad4 [SP6] (ab16667)<\/span><\/strong><\/span><\/div>\n<div class=\"legend__description\">\n<p>ab16667 \u5728\u798f\u723e\u99ac\u6797\u56fa\u5b9a\u77f3\u881f\u5305\u57cb\u7684\u4eba\u7d50\u8178\u764c\u7d44\u7e54\u5207\u7247\u4e2d\u67d3\u8272 Ki67 \u7684 IHC \u5716\u50cf\u3002\u5c07\u8207 ab16667 \u4ee5 1\/200 (0.145 \u03bcg\/ml) \u7a00\u91cb\u5ea6\u5b75\u80b2\u4e14\u5373\u7528\u578b\u5c71\u7f8a\u6297\u5154 IgG H&amp;L\uff08HRP \u805a\u5408\u7269\uff09(\u00a0<a href=\"https:\/\/www.abcam.com\/ab214880.html\">ab214880<\/a>\u00a0) \u7684\u5207\u7247\u7528\u4f5c\u4e8c\u6297\u3002\u5c0d\u4eba\u7d50\u8178\u764c\u7684\u967d\u6027\u67d3\u8272\u3002\u5c07\u5207\u7247\u8207 ab16667 \u5728 4\u00b0C \u4e0b\u5b75\u80b2\u904e\u591c\u3002\u5207\u7247\u7528\u8607\u6728\u7cbe\u8907\u67d3\u3002<\/p>\n<p><a href=\"https:\/\/www.abcam.com\/ab93678.html\">\u4f7f\u7528ab93678<\/a>\u00a0\uff08\u6ab8\u6aac\u9178\u9e7d\u7de9\u885d\u6db2\uff0cpH 6.0\uff09\u9032\u884c\u71b1\u4ecb\u5c0e\u7684\u6297\u539f\u4fee\u5fa9\u3002<\/p>\n<\/div>\n<p>Recombinant rabbit monoclonal [EPR3610]\u00a0<a href=\"https:\/\/www.abcam.com\/ki67-antibody-epr3610-ab92742.html\" target=\"_blank\" rel=\"noopener\">anti-Ki67 (ab92742)<\/a><\/p>\n<ul>\n<li><a href=\"https:\/\/www.abcam.com\/primary-antibodies\/why-a-rabmab-primary-isnt-the-same-as-any-other-antibody-1\" target=\"_blank\" rel=\"noopener\">RabMAb\u00ae<\/a>\u00a0\u5c08\u5229\u6280\u8853\u63d0\u4f9b\u5353\u8d8a\u7684\u7d50\u5408\u89aa\u548c\u529b\u548c\u751f\u7269\u6d3b\u6027\u3002<\/li>\n<li>\u7d93\u9a57\u8b49\u53ef\u7528\u65bc IHC-Fr, WB, IHC-P, Flow Cyt, ICC\/IF \u3002<\/li>\n<li>40 \u591a\u7bc7\u79d1\u5b78\u6587\u737b\u5f15\u7528\uff0c\u8d85\u904e 10 \u5247\u4f7f\u7528\u8005\u5fc3\u5f97\u8a55\u8ad6\uff0c\u5ba2\u6236\u8a55\u50f9\u4e94\u9846\u661f\u3002<\/li>\n<\/ul>\n<p><img decoding=\"async\" src=\"https:\/\/www.abcam.com\/ps\/products\/92\/ab92742\/Images\/ab92742-107962-anti-ki67-antibody-epr3610-immunohistochemistry.jpg\" \/><\/p>\n<p><span style=\"color: #800000;\"><strong><span style=\"font-size: 12pt;\">\u53c3\u8003\u8cc7\u6599<\/span><\/strong><\/span><\/p>\n<ol>\n<li>Feeley, L. P., Mulligan, A. M., Pinnaduwage, D., Bull, S. B. &amp; Andrulis, I. L. Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information. Mod. Pathol. 27, 554\u201361 (2014).<\/li>\n<li>Pathmanathan, N. et al. The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. J. Clin. Pathol. 67, 222\u20138 (2014).<\/li>\n<li>Niikura, N. et al. Prognostic Significance of the Ki67 Scoring Categories in Breast Cancer Subgroups. Clin. Breast Cancer 14, 323\u2013329 (2014).<\/li>\n<li>Rossi, L. et al. Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma. Br. J. Cancer 113, 996\u20131002 (2015).<\/li>\n<li>Reyal, F. et al. Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma. PLoS One 8, e55901 (2013).<\/li>\n<li>Ghanim, B. et al. Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study. Br. J. Cancer 112, 783\u201392 (2015).<\/li>\n<li>Goldhirsch, A. et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann. Oncol. 24, 2206\u201323 (2013).<\/li>\n<li>Andre, F., Arnedos, M., Goubar, A., Ghouadni, A. &amp; Delaloge, S. Ki67\u2014no evidence for its use in node-positive breast cancer. Nat. Rev. Clin. Oncol. 1\u20136 (2015). doi:10.1038\/nrclinonc.2015.46<\/li>\n<li>Harris, L. et al. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Journal of Clinical Oncology 25, 5287\u20135312 (2007).<\/li>\n<li>M.-Y.C., P. et al. An international study to increase concordance in Ki67 scoring. Mod. Pathol. 28, 778\u2013786 (2015).<\/li>\n<li>Institute of Cancer Research, U. K. Trial of Perioperative Endocrine Therapy \u2013 Individualising Care (POETIC). (2015). at &lt;https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02338310?term=NCT02338310&amp;rank=1&gt;<\/li>\n<li>Yuan, J. P. et al. Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer. PLoS One 10, e0122734 (2015).<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Ki67 (\u816b\u7624\u60e1\u6027\u7a0b\u5ea6\u7684\u6a19\u8a18\u7269) | \u764c\u75c7\u7684\u9810\u5f8c\u548c\u6cbb\u7642 Ki67 \u5b58\u5728\u65bc\u7d30\u80de\u6838\u4e2d\uff0c\u662f\u7d30\u80de\u589e\u6b96\u7684\u6a19\u8a8c\u7269\uff0c\u5728\u591a\u7a2e [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":37626,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[5261],"tags":[5968],"_links":{"self":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/43077"}],"collection":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43077"}],"version-history":[{"count":1,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/43077\/revisions"}],"predecessor-version":[{"id":44115,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/43077\/revisions\/44115"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/media\/37626"}],"wp:attachment":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43077"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}